Results 51 to 60 of about 728 (157)
Sugammadex – Reversal of Profound Neuromuscular Blockade in Laparoscopic Surgery [PDF]
Introduction- Sugammadex is a modified γ-cyclodextrin, which promptly reverses the steroidal nondepolarizing neuromuscular blocking agents. Methodology- This interventional trial was commenced after Institutional ethical committee approval in Tagore ...
M. Bastina Jenoffia
core +2 more sources
Peripheral nervous system and neuromuscular disorders in the emergency department: A review
Academic Emergency Medicine, Volume 31, Issue 4, Page 386-397, April 2024.Abstract Introduction Acute presentations and emergencies in neuromuscular disorders (NMDs) often challenge clinical acumen. The objective of this review is to refine the reader's approach to history taking, clinical localization and early diagnosis, as well as emergency management of neuromuscular emergencies.
Ajith Sivadasan +3 more
wiley +1 more source
Cost-Efficiency of Sugammadex Versus Neostigmine/Robinul in Reversing Neuromuscular Blockade [PDF]
, 2019 As healthcare costs in the United States continue to rise, healthcare providers must do their part to negate the expenses incurred by hospitals and patients.
Fryfogle, Joel
core +1 more source
Clinical and Translational Science, Volume 17, Issue 1, January 2024.Abstract The rapid reversal of deep neuromuscular blockade (NMB) is important but remains challenging. This study aimed to evaluate the efficacy and safety of adamgammadex versus sugammadex in reversing deep rocuronium‐induced NMB. This multicenter, randomized, phase IIb study included 80 patients aged 18–64 years, American Society of Anesthesiologists
Yanhua Zhao +10 more
wiley +1 more source
Case Reports in Anesthesiology, Volume 2024, Issue 1, 2024.Patients with very long‐chain acyl‐CoA dehydrogenase deficiency (VLCADD) are prone to hypoglycemia and clinical decompensation when metabolic demands of the body are not met. We present a pediatric patient with VLCADD who underwent a posterior spinal fusion for scoliosis requiring intraoperative neurophysiology monitoring.
Anna Tanaka +5 more
wiley +1 more source
Effect of priming in shortening onset of pipecuronium, a new nondepolarizing neuromuscular blocker.
Revista brasileira de anestesiologia, 2009 One of the most important neuromuscular blockers property is short onset, allowing early tracheal intubation. Low nondepolarizing blocker dose before the full dose is known to decrease the onset of most neuromuscular blockers. Pipecuronium bromide is a long-lasting aminosteroid with major cardiovascular stability, however, with late onset.
José Carlos, Canga +7 more
openaire +1 more source
MONITORING NEUROMUSCULAR BLOCKADE AT THE ADDUCTOR POLLICIS AND ORBICULARIS OCULI WITH SPLIT DOSING OF MIVACURIUM CHLORIDE [PDF]
, 1994 Twenty ASA class I and II patients between the ages of 15 and 64 years undergoing surgical procedures requiring neuromuscular blockade and general anesthesia were selected at random to participate in this study.
Palmerton, Stephen F.
core +1 more source
Journal of Clinical Pharmacy and Therapeutics, Volume 2024, Issue 1, 2024.Background. Succinylcholine and rocuronium are the predominant neuromuscular blocking agents (NMBAs) used for rapid sequence intubation (RSI) in the emergency department (ED). Prior studies have found reduced first‐attempt intubation success (FAIS) with rocuronium compared to succinylcholine.
Helen Y. Wang +5 more
wiley +1 more source
Rocuronium and Malignant Hyperthermia [PDF]
, 2012 Authors response to a comment on: Beggs A, McCann J, Powers J. “Delayed-onset malignant hyperthermia in association with rocuronium use ” Am J Health-Syst Pharm 2012; 69:1128 ...
Beggs, Ashton E., McCann, Jennifer Quinn
core +2 more sources
A Normal Distribution Model for the Pharmacodynamics of Nondepolarizing Neuromuscular Blockers [PDF]
Anaesthesia and Intensive Care, 1997 T A, Torda, G G, Graham, N R, Warwick
openaire +2 more sources